Search Results - "Lefort, Mathilde"

Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France.

Authors: Lefort, Mathilde Dejardin, Olivier Berger, Eric et al.

Source: Multiple Sclerosis Journal. Jan2025, Vol. 31 Issue 1, p69-80. 12p.

Association between education level and disability progression in patients with multiple sclerosis in France.

Authors: Lefort, Mathilde Dejardin, Olivier Berger, Eric et al.

Source: Multiple Sclerosis Journal. Jan2025, Vol. 31 Issue 1, p59-68. 10p.

Facilitating access to the renal transplant waiting list does not increase the number of transplantations: comparative study of two French regions.

Authors: Lefort, Mathilde Vigneau, Cécile Laurent, Annelen et al.

Source: Clinical Kidney Journal. Dec2016, Vol. 9 Issue 6, p849-857. 9p.

COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients.

Authors: Leguy, Soizic Lefort, Mathilde Lescot, Lucile et al.

Source: Journal of Neurology. Oct2022, Vol. 269 Issue 10, p5571-5581. 11p.

Disability progression in multiple sclerosis patients using early first‐line treatments.

Authors: Lefort, Mathilde Vukusic, Sandra Casey, Romain et al.

Source: European Journal of Neurology. Sep2022, Vol. 29 Issue 9, p2761-2771. 11p.

Subjects: Multiple sclerosis, Glatiramer acetate, Disabilities, Older patients, Treatment delay (Medicine), People with disabilities

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.

Authors: Sharmin, Sifat Lefort, Mathilde Andersen, Johanna Balslev et al.

Source: CNS Drugs. Nov2021, Vol. 35 Issue 11, p1217-1232. 16p.

Subjects: Natalizumab, Proportional hazards models, Magnetic resonance imaging, Disease relapse, Multiple sclerosis, Fingolimod, Subgroup analysis (Experimental design)

Long‐term effect of first‐line injectable multiple sclerosis treatments: Input of a time‐dependent propensity score.

Authors: Lefort, Mathilde Foucher, Yohann Lenain, Remi et al.

Source: Pharmacoepidemiology & Drug Safety. Dec2020, Vol. 29 Issue 12, p1680-1688. 9p.

Sex differences in adherence to antihypertensive treatment in patients aged above 55: The French League Against Hypertension Survey (FLAHS).

Authors: Lefort, Mathilde Neufcourt, Lola Pannier, Bruno et al.

Source: Journal of Clinical Hypertension. Oct2018, Vol. 20 Issue 10, p1496-1503. 8p.

Limited added value of systematic spinal cord MRI vs brain MRI alone to classify patients with MS as active or inactive during follow-up.

Authors: Hong, Jérémy Gaubert, Malo Lefort, Mathilde et al.

Source: Journal of Neurology. Apr2025, Vol. 272 Issue 4, p1-9. 9p.

Categorical state sequence analysis and regression tree to identify determinants of care trajectory in chronic disease: Example of end-stage renal disease.

Authors: Le Meur, Nolwenn Vigneau, Cécile Lefort, Mathilde et al.

Source: Statistical Methods in Medical Research. Jun2019, Vol. 28 Issue 6, p1731-1740. 10p.

A cross-sectional study on infectious health risks regarding freshwater sports practice in Brittany, France.

Authors: Velardo, Fanny Bouziri, Hanifa Adélaïde, Lucie et al.

Source: Journal of Water & Health. Feb2022, Vol. 20 Issue 2, p356-368. 13p.

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment.

Authors: Kammerer-Jacquet, Solène-Florence Brunot, Angelique Bensalah, Karim et al.

Source: Urologic Oncology. Oct2017, Vol. 35 Issue 10, p603.e7-603.e14. 1p.

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.

Authors: Jouvenot G Courbon G Lefort M et al.

Corporate Authors: Jouvenot G Courbon G Lefort M et al.

Source: JAMA neurology [JAMA Neurol] 2024 May 01; Vol. 81 (5), pp. 490-498.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Observational Study; Multicenter Study

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Authors: Robin C Rollot F Lefort M et al.

Corporate Authors: Robin C Rollot F Lefort M et al.

Source: Neurology [Neurology] 2025 Aug 12; Vol. 105 (3), pp. e213744. Date of Electronic Publication: 2025 Jul 16.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients.

Authors: Lescot L Lefort M Leguy S et al.

Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Dec; Vol. 68, pp. 104122. Date of Electronic Publication: 2022 Aug 15.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France.

Authors: Leblanc S Lefort M Le Page E et al.

Source: Expert review of neurotherapeutics [Expert Rev Neurother] 2022 May; Vol. 22 (5), pp. 411-418. Date of Electronic Publication: 2022 Apr 05.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101129944 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8360 (Electronic) Linking ISSN: 14737175 NLM ISO Abbreviation: Expert Rev Neurother Subsets: MEDLINE

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.

Authors: Andersen JB Sharmin S Lefort M et al.

Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 Aug; Vol. 53, pp. 103012. Date of Electronic Publication: 2021 May 08.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression.

Authors: Kammerer-Jacquet SF Brunot A Lefort M et al.

Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2019 Jun; Vol. 17 (3), pp. 169-176.e1. Date of Electronic Publication: 2019 Feb 04.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

[Glioblastoma and nursing care in neurosurgery].

Transliterated Title: Glioblastome et soins infirmiers en neurochirurgie.

Authors: Lefort M; Hôpital d'instruction des armées Percy, 101 avenue Henri Barbusse, BP 406, 92141 Clamart Cedex, France. Electronic address: firemath_22@hotmail.fr.

Source: Revue de l'infirmiere [Rev Infirm] 2017 Feb; Vol. 66 (228), pp. 26-28.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Masson Country of Publication: France NLM ID: 1267175 Publication Model: Print Cited Medium: Print ISSN: 1293-8505 (Print) Linking ISSN: 12938505 NLM ISO Abbreviation: Rev Infirm